Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Five U.S. states sue Purdue Pharma over marketing, selling of opioids

Written by: | no-reply@reuters.com | Dated: Thursday, May 16th, 2019

 

(Reuters) – Five U.S. states on Thursday filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin, contributing to a nationwide epidemic.

Iowa, Kansas, Maryland, West Virginia and Wisconsin joined 39 other states that have sued Purdue Pharma, Iowa Attorney General Tom Miller said in a statement.

The company’s former president Richard Sackler is also a defendant in some of the lawsuits.

State officials accused Purdue Pharma of repeatedly making false and deceptive claims that opioids, including its OxyContin, were safe for a wide range of patients seeking to reduce pain.

Purdue Pharma had no immediate comment, but was expected to comment later on Thursday.

State and local governments have filed hundreds of lawsuits against companies associated with opioids, including oxycodone and other prescription painkillers.

They have accused drugmakers, including Purdue, of deceptive marketing, and distributors such as AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp of ignoring how opioids were being used illegally.

Opioids, including prescription painkillers and heroin, played a role in a record 47,600 U.S. overdose deaths in 2017, the U.S. Centers for Disease Control and Prevention has said.

 

Reporting by Jonathan Stempel in New York; editing by Bill Berkrot

 

Reuters source:

https://www.reuters.com/article/us-usa-opioids-purdue-pharma/five-u-s-states-sue-purdue-pharma-over-marketing-selling-of-opioids-idUSKCN1SM1SV

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom